S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Fed's Shocking New Plan to Control Your Money (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
Fed's Shocking New Plan to Control Your Money (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Fed's Shocking New Plan to Control Your Money (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
Fed's Shocking New Plan to Control Your Money (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Fed's Shocking New Plan to Control Your Money (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
Fed's Shocking New Plan to Control Your Money (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 More Downgrades To Put On Your Buy List 
Three Pullback Opportunities in Tech Right Now
Fed's Shocking New Plan to Control Your Money (Ad)
Three Mid Caps Wall Street Sees Doubling Within 12 Months
The Most Important Warren Buffett Stock for Investors: His Own
Fed's Shocking New Plan to Control Your Money (Ad)
Dave & Buster’s Rebound Could Score for Investors 
Micron Technology Goes on Breakout Watch
CVE:WED

Westaim - WED Competitors

C$2.90
0.00 (0.00%)
(As of 03/29/2023 05:12 PM ET)
Add
Compare
Today's Range
C$2.87
C$2.91
50-Day Range
C$2.82
C$3.00
52-Week Range
C$2.27
C$3.00
Volume
46,000 shs
Average Volume
77,470 shs
Market Capitalization
C$410.03 million
P/E Ratio
N/A
Dividend Yield
6.21%
Price Target
N/A

WED vs. GS, FTN, AGF.B, LBS, XLY, BK, OLY, PBY.UN, FSZ, and SBC

Should you be buying Westaim stock or one of its competitors? The main competitors of Westaim include Gluskin Sheff + Associates (GS), Financial 15 Split (FTN), AGF Management (AGF.B), Life & Banc Split (LBS), Auxly Cannabis Group (XLY), Canadian Banc (BK), Olympia Financial Group (OLY), Canso Credit Income Fund (PBY.UN), Fiera Capital (FSZ), and Brompton Split Banc (SBC). These companies are all part of the "asset management" industry.

Westaim vs.

Westaim (CVE:WED) and Gluskin Sheff + Associates (TSE:GS) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership, community ranking and earnings.

Gluskin Sheff + Associates has higher revenue and earnings than Westaim. Westaim is trading at a lower price-to-earnings ratio than Gluskin Sheff + Associates, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Westaim-C$899 thousand-456.10-C$8.17 million-C$0.08-36.25
Gluskin Sheff + AssociatesC$113.89 million3.90C$25.29 millionC$0.8117.58

Gluskin Sheff + Associates received 227 more outperform votes than Westaim when rated by MarketBeat users. However, 71.14% of users gave Westaim an outperform vote while only 56.73% of users gave Gluskin Sheff + Associates an outperform vote.

CompanyUnderperformOutperform
WestaimOutperform Votes
106
71.14%
Underperform Votes
43
28.86%
Gluskin Sheff + AssociatesOutperform Votes
333
56.73%
Underperform Votes
254
43.27%

Westaim pays an annual dividend of C$0.18 per share and has a dividend yield of 6.2%. Gluskin Sheff + Associates pays an annual dividend of C$1.00 per share and has a dividend yield of 7.0%. Westaim pays out -225.0% of its earnings in the form of a dividend. Gluskin Sheff + Associates pays out 123.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Gluskin Sheff + Associates' return on equity of 0.00% beat Westaim's return on equity.

Company Net Margins Return on Equity Return on Assets
Westaim N/A -2.43% -1.37%
Gluskin Sheff + Associates N/A N/A N/A

10.2% of Westaim shares are owned by institutional investors. 15.2% of Westaim shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Gluskin Sheff + Associates had 2 more articles in the media than Westaim. MarketBeat recorded 2 mentions for Gluskin Sheff + Associates and 0 mentions for Westaim. Gluskin Sheff + Associates' average media sentiment score of 0.00 beat Westaim's score of -0.39 indicating that Gluskin Sheff + Associates is being referred to more favorably in the news media.

Company Overall Sentiment
Westaim Neutral
Gluskin Sheff + Associates Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Westaim
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Gluskin Sheff + Associates
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Gluskin Sheff + Associates beats Westaim on 11 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of CVE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WED vs. The Competition

MetricWestaimAsset Management IndustryFinance SectorCVE Exchange
Market CapC$410.03MC$637.19MC$5.99BC$68.14M
Dividend Yield10.32%15.79%8.35%13.57%
P/E Ratio-36.25663.09140.2417.62
Price / Sales-456.1018,713.935,960.361,266.46
Price / Cash1.0080.8831.6730.80
Price / Book1.241.643.504.75
Net Income-C$8.17M-C$54,039.00C$645.54M-C$5.71M
7 Day Performance-1.36%13.17%6.52%0.99%
1 Month Performance-1.36%-4.19%-5.53%-1.28%
1 Year Performance23.40%90.11%11.22%-5.19%

Westaim Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GS
Gluskin Sheff + Associates
0 of 5 stars
N/AN/A+0.0%C$444.64MC$113.89M17.58142News Coverage
FTN
Financial 15 Split
0 of 5 stars
C$9.24
+0.5%
N/A-20.5%C$324.32MC$1.81M-9.73N/A
AGF.B
AGF Management
1.9585 of 5 stars
C$7.77
+0.4%
C$8.88
+14.2%
+1.6%C$509.32MC$469M8.93652
LBS
Life & Banc Split
0 of 5 stars
C$8.72
+1.4%
N/A-23.0%C$306.94MC$-40,230,000.00-6.71N/APositive News
XLY
Auxly Cannabis Group
0 of 5 stars
C$0.39
+5.4%
C$0.11
-71.8%
+0.0%C$289.90MC$35.07M-2.10N/ANews Coverage
Gap Up
BK
Canadian Banc
0 of 5 stars
C$13.46
-0.6%
N/A-11.4%C$248.88MC$6.92M-33.652,018
OLY
Olympia Financial Group
0 of 5 stars
C$85.50
-0.1%
N/A+71.0%C$206.06MC$72.16M14.20220
PBY.UN
Canso Credit Income Fund
0 of 5 stars
C$14.15
+0.3%
N/A-0.9%C$204.50MN/A0.00N/ANews Coverage
FSZ
Fiera Capital
2.1525 of 5 stars
C$7.55
-2.1%
C$9.57
+26.8%
-28.2%C$628.39MC$681.44M31.46844
SBC
Brompton Split Banc
0 of 5 stars
C$10.99
+1.2%
N/A-21.8%C$173.86MC$-8,520,000.00-8.79N/A
This page (CVE:WED) was last updated on 3/30/2023 by MarketBeat.com Staff